Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

521 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Post-acute phase and sequelae management of epidermal necrolysis: an international, multidisciplinary DELPHI-based consensus.
Ingen-Housz-Oro S, Schmidt V, Ameri MM, Abe R, Brassard A, Mostaghimi A, Paller AS, Romano A, Didona B, Kaffenberger BH, Ben Said B, Thong BYH, Ramsay B, Brezinova E, Milpied B, Mortz CG, Chu CY, Sotozono C, Gueudry J, Fortune DG, Dridi SM, Tartar D, Do-Pham G, Gabison E, Phillips EJ, Lewis F, Salavastru C, Horvath B, Dart J, Setterfield J, Newman J, Schulz JT, Delcampe A, Brockow K, Seminario-Vidal L, Jörg L, Watson MP, Gonçalo M, Lucas M, Torres M, Noe MH, Hama N, Shear NH, O'Reilly P, Wolkenstein P, Romanelli P, Dodiuk-Gad RP, Micheletti RG, Tiplica GS, Sheridan R, Rauz S, Ahmad S, Chua SL, Flynn TH, Pichler W, Le ST, Maverakis E, Walsh S, French LE, Brüggen MC. Ingen-Housz-Oro S, et al. Among authors: le st, french le. Orphanet J Rare Dis. 2023 Feb 22;18(1):33. doi: 10.1186/s13023-023-02631-7. Orphanet J Rare Dis. 2023. PMID: 36814255 Free PMC article.
Drug-Induced Pyoderma Gangrenosum: A Review.
Wang JY, French LE, Shear NH, Amiri A, Alavi A. Wang JY, et al. Among authors: french le. Am J Clin Dermatol. 2018 Feb;19(1):67-77. doi: 10.1007/s40257-017-0308-7. Am J Clin Dermatol. 2018. PMID: 28624960 Review.
Assessment of Treatment Approaches and Outcomes in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Insights From a Pan-European Multicenter Study.
Kridin K, Brüggen MC, Chua SL, Bygum A, Walsh S, Nägeli MC, Kucinskiene V, French L, Tétart F, Didona B, Milpied B, Ranki A, Salavastru C, Brezinová E, Divani-Patel S, Lorentzen T, Nagel JL, Valiukeviciene S, Karpaviciute V, Tiplica GS, Oppel E, Oschmann A, de Prost N, Vorobyev A, Ingen-Housz-Oro S. Kridin K, et al. JAMA Dermatol. 2021 Oct 1;157(10):1182-1190. doi: 10.1001/jamadermatol.2021.3154. JAMA Dermatol. 2021. PMID: 34431984 Free PMC article.
Severe blistering eruptions induced by immune checkpoint inhibitors: a multicentre international study of 32 cases.
Ingen-Housz-Oro S, Milpied B, Badrignans M, Carrera C, Elshot YS, Bensaid B, Segura S, Apalla Z, Markova A, Staumont-Sallé D, Marti-Marti I, Giavedoni P, Chua SL, Darrigade AS, Dezoteux F, Starace M, Torre AC, Riganti J, de Prost N, Lebrun-Vignes B, Bauvin O, Walsh S, Ortonne N, French LE, Sibaud V. Ingen-Housz-Oro S, et al. Among authors: french le. Melanoma Res. 2022 Jun 1;32(3):205-210. doi: 10.1097/CMR.0000000000000819. Epub 2022 Mar 29. Melanoma Res. 2022. PMID: 35377864 Free PMC article.
Drug reactions with eosinophilia and systemic symptoms induced by immune checkpoint inhibitors: an international cohort of 13 cases.
Ingen-Housz-Oro S, Milpied B, Bensaid B, Elshot Y, Brüggen MC, Starace M, Kaffenberger BH, Carrera C, Pham-Ledard A, Freites-Martinez A, Sanchez-Pena P, Lebrun-Vignes B, French LE, Sibaud V. Ingen-Housz-Oro S, et al. Among authors: french le. Melanoma Res. 2023 Apr 1;33(2):155-158. doi: 10.1097/CMR.0000000000000877. Epub 2023 Feb 6. Melanoma Res. 2023. PMID: 36749114
Development and Validation of a Novel Score to Predict Mortality in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: CRISTEN.
Hama N, Sunaga Y, Ochiai H, Kokaze A, Watanabe H, Kurosawa M, Azukizawa H, Asada H, Watanabe Y, Yamaguchi Y, Aihara M, Mizukawa Y, Ohyama M, Hashizume H, Nakajima S, Nomura T, Kabashima K, Tohyama M, Hasegawa A, Takahashi H, Mieno H, Ueta M, Sotozono C, Niihara H, Morita E, Brüggen MC, Feingold IM, Jeschke MG, Dodiuk-Gad RP, Oppel EM, French LE, Chen WT, Chung WH, Chu CY, Kang HR, Ingen-Housz-Oro S, Nakamura K, Sueki H, Abe R. Hama N, et al. Among authors: french le. J Allergy Clin Immunol Pract. 2023 Oct;11(10):3161-3168.e2. doi: 10.1016/j.jaip.2023.07.001. Epub 2023 Jul 8. J Allergy Clin Immunol Pract. 2023. PMID: 37429419
Subjective assessments in pyoderma gangrenosum diagnostic frameworks undermine framework agreement.
Nusbaum KB, Boettler M, Korman AM, Alavi A, Alloo A, Dissemond J, French LE, Huang WW, Kolios AGA, Marzano AV, Micheletti RG, Mostaghimi A, Ortega-Loayza AG, Rosenbach M, Schreml S, Tolkachjov SN, Kaffenberger BH. Nusbaum KB, et al. Among authors: french le. Int J Dermatol. 2024 Feb;63(2):e67-e69. doi: 10.1111/ijd.16952. Epub 2023 Dec 3. Int J Dermatol. 2024. PMID: 38044552 No abstract available.
Eligibility Criteria for Active Ulcerative Pyoderma Gangrenosum in Clinical Trials: A Delphi Consensus on Behalf of the UPGRADE (Understanding Pyoderma Gangrenosum: Review and Assessment of Disease Effects) Group.
Kamal K, Xia E, Li SJ, Alavi A, Cogen AL, Firooz A, Marzano AV, Kaffenberger BH, Sibbald C, Fernandez AP, Callen JP, Dissemond J, Gontijo JRV, Shams K, Gerbens LA, French LE, Gould LJ, Bissonnette R, Shaigany S, Tolkachjov S, Yamamoto T, Wei-Ting Huang W, Ortega-Loayza AG, Mostaghimi A. Kamal K, et al. Among authors: french le. J Invest Dermatol. 2023 Dec 16:S0022-202X(23)03193-7. doi: 10.1016/j.jid.2023.12.006. Online ahead of print. J Invest Dermatol. 2023. PMID: 38110114
521 results